| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e8d2afa63dbd8bbb90545722d3f54c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b36e068a067c08f580b66d5cdd58970 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-11 |
| filingDate |
2017-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28045da299b252151b59ee60f939217e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f666923d7d0f12fd14cea5a4f25929c5 |
| publicationDate |
2018-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-108697667-A |
| titleOfInvention |
Pharmaceutical composition for treating cancer containing polyphenol compound as active ingredient |
| abstract |
The present invention relates to a pharmaceutical composition for treating cancer containing a polyphenol compound as an active ingredient. The pharmaceutical composition of this study is very effective for the treatment and prognosis improvement of cancer stem cells or cancer tissues with a large number of cancer stem cells (eg, poorly differentiated cancer). In addition, when a polyphenol compound and a biguanide compound and an anticancer agent are administered to cancer cells in combination, a significantly improved inhibitory effect on the growth of cancer cells is observed compared to their respective administrations, and thus the combination is expected to find great value in the field of cancer treatment. good application. |
| priorityDate |
2016-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |